Combinati Incorporated

Palo Alto, CA · Founded 2015 · Medtech · Acquired

Digital Melt Curve Analysis (DMCA) platform for nucleic acid quantification and mutation detection

Claim this profile

Follows are private to you and power your alerts

Updated · combinati.com

Sector
Medtech
Headquarters
Palo Alto, CA
Founded
2015
Latest Form D
$5.8M, May 2018
Total capital
$13.7M
Federal grants
$7.9M
15 awards · 2016–2021
Rank in peer group#252 of 538
Private capital raised
$5.8M
1 Form D · last May 2018
101 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
14
26 pending · first 2017
Rank in peer group#43 of 538

Capital timeline

201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $13.7M$700K$1.8M$600K$600K$773K$773K1st Form D$5.8M
201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $13.7M$700K$1.8M$773K$773K1st Form D$5.8M

Latest events

  • Federal grantHealth and Human S · Phase II · Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring$773K
  • Federal grantHealth and Human S · Phase II · Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring$773K
  • Federal grantHealth and Human S · Phase II · Array Imaging digital PCR Platform$600K
  • Federal grantHealth and Human S · Phase II · Array Imaging digital PCR Platform$600K
  • Federal grantHealth and Human S · Phase I · Integrated Microbial Screening and Antimicrobial Susceptibility Test on Microfluidic Digital Array for Diagnosis of Urinary Tract Infections$225K
  • Federal grantHealth and Human S · Phase II · Array Imaging digital PCR Platform$600K
  • Federal grantHealth and Human S · Phase II · Array Imaging digital PCR Platform$1.8M
  • Private capital raisedForm D · SEC · 1st filing$5.8M
Show 8 earlier federal awards
  • Federal grantHealth and Human S · Phase I · Single-color Multiplexed Digital PCR via High Resolution Melt Analysis of Endpoint Digital PCR Partitions$225K
  • Federal grantHealth and Human S · Phase I · High Density Array Digital PCR for Cancer Rare Mutation Quantification$225K
  • Federal grantHealth and Human S · Phase I · High Density Array Digital PCR for Cancer Rare Mutation Quantification$225K
  • Federal grantHealth and Human S · Phase I · Integrated Digital PCR Platform with a Micromolded Siphoning Array$350K
  • Federal grantHealth and Human S · Phase I · Micromolded Digital Nucleic Acid Test Consumable$215K
  • Federal grantHealth and Human S · Phase I · Micromolded Digital Nucleic Acid Test Consumable$215K
  • Federal grantHealth and Human S · Phase I · Integrated Digital PCR Platform with a Micromolded Siphoning Array$700K
  • Federal grantHealth and Human S · Phase I · Integrated Digital PCR Platform with a Micromolded Siphoning Array$350K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

23months

from Combinati Incorporated’s first federal award to its first private round.

First federal award · Jun 2016
Health and Human S · $350K
First Form D · May 2018
$5.8M · 1st Form D
Awards before first raise
7 awards

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#252 · top 47%
  • Granted patents#43 · top 8%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Ju-Sung (Paul) HungResearcherExecutive Officer, DirectorLinked by $2.8M in grants as PI
  • Charles CollinsDirectorNamed in SEC Form D filings
  • Michael MokelkeDirectorNamed in SEC Form D filings

What it has protected

USPTO · 14 granted of 40
Show all 40 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .